Liquid dosage forms of non-enterically coated proton pump inhibitors
CA 2490147 C · Owner: Takeda Pharmaceuticals North America, Inc. · Inventors: Taneja, Rajneesh
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Provided herein are formulations of acid labile drugs such as proton pump , inhibitors (PPI). The formulations comprise a PPI and a liquid vehicle typically having a pH greater than 6.5 and a viscosity sufficient to maintain a uniform suspension of the PPI for 15 minutes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 2, 2003 and granted January 14, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 2, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 2, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.